Add to ORKGIn 2007, Vermont enacted the Prescription Confidentiality Law, prohibiting pharmacies from selling “prescriber-identifiable” prescription information to data-mining companies such as IMS Health and Verispan. These companies aggregate such data and sell them to many groups, including drug companies, so when drug sales representatives visit a physician, they can know exactly what prescriptions the physician has written
Recent decisions have caused the FDA to question whether its regulations of prescription drug promot...
Trade secrets have traditionally been considered to be property interests under the law protected by...
This Court should refuse to apply the First Amendment to Vermont’s Prescription Confidentiality Law ...
In 2007, Vermont enacted the Prescription Confidentiality Law, prohibiting pharmacies from selling “...
In 2011, the United States Supreme Court in Sorrell v. IMS Health Inc. struck down a Vermont law tha...
Pharmaceutical companies have strong economic interests in influencing physician-prescribing behavio...
Is more information always better? First Amendment commercial speech jurisprudence takes this as a g...
This article focuses on the unique nature of prohibited disclosures within the health care field. S...
This brief was written in support of Vermont’s Prescription Confidentiality Law, which regulates the...
On May 19, 2003, the Supreme Court in Pharmaceutical Research and Manufacturers of America v. Walsh ...
On April 26, 2011, the US Supreme Court will hear oral arguments in the Vermont data mining case, So...
In 2006, New York City began a mandatory reporting system for laboratories to submit blood sugar (A1...
Advertising prescription drugs directly to consumers is a recent phenomenon and has sparked much eth...
This paper seeks (1) to provide the background necessary to understand current commercial speech jur...
Food and Drug Administration (FDA) rules are often forged in crisis. After the 1937 sulfanilamide di...
Recent decisions have caused the FDA to question whether its regulations of prescription drug promot...
Trade secrets have traditionally been considered to be property interests under the law protected by...
This Court should refuse to apply the First Amendment to Vermont’s Prescription Confidentiality Law ...
In 2007, Vermont enacted the Prescription Confidentiality Law, prohibiting pharmacies from selling “...
In 2011, the United States Supreme Court in Sorrell v. IMS Health Inc. struck down a Vermont law tha...
Pharmaceutical companies have strong economic interests in influencing physician-prescribing behavio...
Is more information always better? First Amendment commercial speech jurisprudence takes this as a g...
This article focuses on the unique nature of prohibited disclosures within the health care field. S...
This brief was written in support of Vermont’s Prescription Confidentiality Law, which regulates the...
On May 19, 2003, the Supreme Court in Pharmaceutical Research and Manufacturers of America v. Walsh ...
On April 26, 2011, the US Supreme Court will hear oral arguments in the Vermont data mining case, So...
In 2006, New York City began a mandatory reporting system for laboratories to submit blood sugar (A1...
Advertising prescription drugs directly to consumers is a recent phenomenon and has sparked much eth...
This paper seeks (1) to provide the background necessary to understand current commercial speech jur...
Food and Drug Administration (FDA) rules are often forged in crisis. After the 1937 sulfanilamide di...
Recent decisions have caused the FDA to question whether its regulations of prescription drug promot...
Trade secrets have traditionally been considered to be property interests under the law protected by...
This Court should refuse to apply the First Amendment to Vermont’s Prescription Confidentiality Law ...